Jules L.L.M. Coenen
-
- Prostate Cancer Treatment and Research 10
-
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 2
-
- Radiopharmaceutical Chemistry and Applications 8
- Hematology top 10%
- Multiple Myeloma Research and Treatments 2
-
- Cancer, Lipids, and Metabolism 2
-
- Management of metastatic bone disease 2
- Co-authors
- Andries M. BergmanJacques C. de GraafDirk Th. SleijferInge M. van OortFrank G. A. JansmanJ. R. B. J. BrouwersAlfons J.M. van den EertweghPaul Hamberg
- Partner nations
- NetherlandsUnited States
In The Last Decade
Jules L.L.M. Coenen
19 papers receiving 451 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 261
- Oncology 195
- Radiology, Nuclear Medicine and Imaging 160
- Hematology 75
- Cancer Research 90
Countries citing papers authored by Jules L.L.M. Coenen
This map shows the geographic impact of Jules L.L.M. Coenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jules L.L.M. Coenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jules L.L.M. Coenen more than expected).
Fields of papers citing papers by Jules L.L.M. Coenen
This network shows the impact of papers produced by Jules L.L.M. Coenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jules L.L.M. Coenen. The network helps show where Jules L.L.M. Coenen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jules L.L.M. Coenen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 3 | |
| 2 | 2020 | 17 | |
| 3 | 2020 | 25 | |
| 4 | 2019 | 8 | |
| 5 | 2019 | 0 | |
| 6 | 2019 | 19 | |
| 7 | 2018 | 30 | |
| 8 | 2016 | 10 | |
| 9 | 2015 | 10 | |
| 10 | 2014 | 38 | |
| 11 | 2013 | 26 | |
| 12 | 2013 | 109 | |
| 13 | 2008 | 31 | |
| 14 | 2005 | 5 | |
| 15 | 2005 | 4 | |
| 16 | Relationship between pharmacokinetics of 5-FU in plasma and in saliva, and toxicity of 5-fluorouracil/folinic acid. | 2003 | 7 |
| 17 | 2001 | 55 | |
| 18 | 2000 | 27 | |
| 19 | 1998 | 12 | |
| 20 | 1996 | 33 |
About Jules L.L.M. Coenen
Jules L.L.M. Coenen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 469 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), HER2/EGFR in Cancer Research (2 papers) and Management of metastatic bone disease (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (261 citations), Oncology (195 citations) and Radiology, Nuclear Medicine and Imaging (160 citations). Jules L.L.M. Coenen has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Andries M. Bergman, Jacques C. de Graaf, Dirk Th. Sleijfer, Inge M. van Oort, Frank G. A. Jansman, J. R. B. J. Brouwers, Alfons J.M. van den Eertwegh, Paul Hamberg, Maartje Los and Vincent van der Noort. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.